Kirill Osipov comments on regulation of dependent inventions in Russia

Kirill Osipov, the Head of Legal Department of ARS-Patent, commented on regulation of dependent inventions in Russia for the newspaper “Pharmvestnik” in the light of the Moscow Arbitration Court’s Decision of June 1, 2018, according to which, a first compulsory license may be granted in Russia to a medicament comprising INN Lenalidomide.

More details are available at Pharmvestnik’s website.

Pharmvestnik is the leading specialized weekly newspaper covering the Russian pharmaceutical and related industries with a circulation of 16 200 copies. The newspaper has been issued since 1994.

Make an enquiry

Latest News

Reimbursement of expenses when considering the disputes in Rospatent

2024-02-21

In accordance with the new Federal Law No. 390361-8 of January 30, 2024, with proposed amendments to Article 1248 of the Civil Code of the Russian Fed...

Read more
Amendments and addenda to the Patent Regulations under the EAPC

2024-01-12

As of January 1, 2024, amendments and addenda to Part I «Inventions» and Part II «Industrial Designs» of the Patent Regulations to the Eurasian Pa...

Read more

View all our News

MEET WITH US

Meet ARS-Patent at the 2023 AIPPI World Congress

2023-09-26

The 2023 AIPPI World Congress will bring together up to 2000 intellectual property professionals from around the world for a prestigious event, which ...

Read more
2023 IPO Annual Meeting

2023-08-16

We are glad to announce that Pavel Vorobev, the Client Manager and Patent Attorney of ARS-Patent, will attend the 2023 Intellectual Property Owners As...

Read more

See all Events

Back top